24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson’s disease

Levodopa-carbidopa intestinal gel (LCIG) is effective for the control of motor fluctuations in Parkinson’s disease (PD). The objective of this study is to report the reduction of dyskinesias after transitioning from 16 to 24-h/day LCIG infusion. From a cohort of 74 PD patients treated with LCIG for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:NPJ Parkinsons Dis
Main Authors: Cruse, Belinda, Morales-Briceño, Hugo, Chang, Florence C F, Mahant, Neil, Ha, Ainhi D, Kim, Samuel D, Wolfe, Nigel, Kwan, Vu, Tsui, David S, Griffith, Jane M, Galea, Donna, Fung, Victor S C
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6243994/
https://ncbi.nlm.nih.gov/pubmed/30480087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41531-018-0070-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados